参考文献/References:
[1]Fan C,Tu C,Qi P,et al.GPC6 Promotes Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma[J].J Cancer,2019,10(17):3926-3932.[2]Sun G,Li Z,Rong D,et al.Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges[J].Mol Ther Oncolytics,2021,21:183-206.[3]Chong ZX,Ho WY,Yeap SK,et al.Single-cell RNA sequencing in human lung cancer: Applications, challenges, and pathway towards personalized therapy[J].J Chin Med Assoc,2021,84(6):563-576.[4]Kan T,Zhang S,Zhou S,et al.Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence[J].Oncogene,2022,41(6):895-906.[5]Ysebaert L,Quillet-Mary A,Tosolini M,et al.Lymphoma Heterogeneity Unraveled by Single-Cell Transcriptomics[J].Front Immunol,2021,12:597651.[6]McGranahan N,Swanton C.Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future[J].Cell,2017,168(4):613-628.[7]Sanger F,Nicklen S,Coulson AR.DNA sequencing with chain-terminating inhibitors[J].Proc Natl Acad Sci U S A.,1977,74(12):5463-5467.[8]Tang F,Barbacioru C,Wang Y,et al.mRNA-Seq whole-transcriptome analysis of a single cell[J].Nat Methods,2009,6(5):377-382.[9]Nagai H,Kim YH.Cancer prevention from the perspective of global cancer burden patterns[J].J Thorac Dis,2017,9(3):448-451.[10]Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.[11]Zhang Y,Rumgay H,Li M,et al.Nasopharyngeal Cancer Incidence and Mortality in 185 Countries in 2020 and the Projected Burden in 2040: Population-Based Global Epidemiological Profiling[J].JMIR Public Health Surveill,2023,9:e49968.[12]宋祎凡,刘晓雪,尹遵栋,等.2018-2020年中国9-45岁女性人乳头瘤病毒疫苗估算接种率[J].中国疫苗和免疫,2021,27(5):570-575.[13]Naik S,Larsen SB,Cowley CJ,et al.Two to Tango: Dialog between Immunity and Stem Cells in Health and Disease[J].Cell,2018,175(4):908-920.[14]Doorbar J,Griffin H.Refining our understanding of cervical neoplasia and its cellular origins[J].Papillomavirus Res,2019,7:176-179.[15]Chumduri C,Gurumurthy RK,Berger H,et al.Opposing Wnt signals regulate cervical squamocolumnar homeostasis and emergence of metaplasia[J].Nat Cell Biol,2021,23(2):184-197.[16]Prasetyanti PR,Medema JP.Intra-tumor heterogeneity from a cancer stem cell perspective[J].Mol Cancer,2017,16(1):41.[17]Li C,Guo L,Li S,et al.Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and transcriptional activities of ECs in CC[J].Mol Ther Nucleic Acids,2021,24:682-694.[18]Casey SC,Amedei A,Aquilano K,et al.Cancer prevention and therapy through the modulation of the tumor microenvironment[J].Semin Cancer Biol,2015,35 Suppl(Suppl):S199-S223.[19]Beuselinck B,Lambrechts D,Van Brussel T,et al.Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib[J].Acta Oncol,2014,53(10):1413-1422.[20]Wijaya J,Fukuda Y,Schuetz JD.Obstacles to Brain Tumor Therapy: Key ABC Transporters[J].Int J Mol Sci,2017,18(12):2544.[21]Li C,Hua K.Dissecting the Single-Cell Transcriptome Network of Immune Environment Underlying Cervical Premalignant Lesion, Cervical Cancer and Metastatic Lymph Nodes[J].Front Immunol,2022,13:897366.[22]周蓉,鹿群,刘国莉,等.早期子宫内膜癌保留生育功能治疗专家共识[J].中国妇产科临床杂志,2019,20(4):369-373.[23]Corzo C,Barrientos Santillan N,Westin SN,et al.Updates on Conservative Management of Endometrial Cancer[J].J Minim Invasive Gynecol,2018,25(2):308-313.[24]Siegel RL,Miller KD,Fuchs HE,et al.Cancer statistics, 2022[J].CA Cancer J Clin,2022,72(1):7-33.[25]Colombo N,Creutzberg C,Amant F,et al.ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up[J].Ann Oncol,2016,27(1):16-41.[26]Hashimoto S,Tabuchi Y,Yurino H,et al.Comprehensive single-cell transcriptome analysis reveals heterogeneity in endometrioid adenocarcinoma tissues[J].Sci Rep,2017,7(1):14225.[27]Zhu Y,Lin X,Zang Y,et al.Identification of ZEB2 as an Immune-Associated Gene in Endometrial Carcinoma and Associated with Macrophage Infiltration by Bioinformatic Analysis[J].J Healthc Eng,2021,2021:4372373.[28]Guo YE,Li Y,Cai B,et al.Phenotyping of immune and endometrial epithelial cells in endometrial carcinomas revealed by single-cell RNA sequencing[J].Aging (Albany NY),2021,13(5):6565-6591.[29]Fu DJ,De Micheli AJ,Bidarimath M,et al.Cells expressing PAX8 are the main source of homeostatic regeneration of adult mouse endometrial epithelium and give rise to serous endometrial carcinoma[J].Dis Model Mech,2020,13(10):dmm047035.[30]Cochrane DR,Campbell KR,Greening K,et al.Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours[J].J Pathol,2020,252(2):201-214.[31]Stuart GC,Kitchener H,Bacon M,et al.2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference[J].Int J Gynecol Cancer,2011,21(4):750-755.[32]Winterhoff BJ,Maile M,Mitra AK,et al.Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells [published correction appears in Gynecol Oncol[J].Gynecol Oncol,2017,144(3):598-606.[33]Hao Q,Li J,Zhang Q,et al.Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma[J].Clin Transl Med,2021,11(8):e500.[34]Geistlinger L,Oh S,Ramos M,et al.Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma[J].Cancer Res,2020,80(20):4335-4345.[35]Izar B,Tirosh I,Stover EH,et al.A single-cell landscape of high-grade serous ovarian cancer[J].Nat Med,2020,26(8):1271-1279.[36]Olbrecht S,Busschaert P,Qian J,et al.High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification[J].Genome Med,2021,13(1):111.[37]Olalekan S,Xie B,Back R,et al.Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics[J].Cell Rep,2021,35(8):109165.[38]Wan C,Keany MP,Dong H,et al.Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer[J].Cancer Res,2021,81(1):158-173.[39]Nath A,Cosgrove PA,Mirsafian H,et al.Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer[J].Nat Commun,2021,12(1):3039.[40]Hu Z,Artibani M,Alsaadi A,et al.The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells[J].Cancer Cell,2020,7(2):226-242.e7.[41]Liang L,Yu J,Li J,et al.Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model[J].Front Oncol,2021,11:711020.